featured
Effects of the Port Delivery System With Ranibizumab in Neovascular AMD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Archway Randomized Phase 3 Trial of the Port Delivery System With Ranibizumab for Neovascular Age-Related Macular Degeneration
Ophthalmology 2021 Sep 28;[EPub Ahead of Print], NM Holekamp, PA Campochiaro, M Chang, D Miller, D Pieramici, AP Adamis, C Brittain, E Evans, D Kaufman, KF Maass, S Patel, S Ranade, N Singh, G Barteselli, C RegilloFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.